Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Sep 04 2021

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-04-2021-1

Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call
Dr. Reddy's Laboratories' next earnings callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Oct 23, 2026 at 10:00 AM EDTRegister

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 04, 2021, titled "Dr. Reddy s Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox).".

View Attachment

6ix hasn’t read this filing yet.

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases